COMMUNIQUÉS West-GlobeNewswire

The McGill University Health Centre’s Dr. Renzo Cecere wins the 2024 Trottier Webster Innovation Award
28/11/2024
MONTREAL, Nov. 28, 2024 (GLOBE NEWSWIRE) -- The McGill University Health Centre (MUHC) Foundation is thrilled to announce that Dr. Renzo Cecere, Cardiac Surgeon at the MUHC and Director of the Myocardial Regeneration [...]
Le Dr Renzo Cecere du Centre universitaire de santé McGill remporte le Prix Trottier-Webster pour l’innovation 2024
28/11/2024
MONTRÉAL, 28 nov. 2024 (GLOBE NEWSWIRE) -- La Fondation du Centre universitaire de santé McGill (CUSM) est ravie d’annoncer que le D r Renzo Cecere, chirurgien cardiaque au CUSM et directeur du Laboratoire de [...]
Extendicare Announces Agreement to Acquire Nine Long-Term Care Homes from Revera
28/11/2024
MARKHAM, Ontario, Nov. 28, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE.TO) announced today that it has entered into an agreement with Revera Inc. (“Revera”) and certain of its [...]
Canada is facing a productivity crisis as employee burnout is a major concern among businesses: New research from HOOPP and Angus Reid Group
28/11/2024
Survey findings show businesses are concerned about employee burnout, but companies that invested in their workers over the last year reported better employee productivity TORONTO, Nov. 28, 2024 (GLOBE NEWSWIRE) -- New [...]
HUTCHMED Announces Continued Inclusion of ORPATHYS® (savolitinib) in the National Reimbursement Drug List in China at Current Terms
28/11/2024
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Nov. 28, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/AIM:HCM; HKEX:13) today announces that following the contract renewal with the China [...]
Mangosteen Marvel MangoSoothe Outperforms Leading Joint Health Supplements
28/11/2024
Naiad's MangoSoothe changed joint health with its single-ingredient mangosteen formula, showing results in just five days. Clinical studies demonstrate 50% reduced discomfort in seniors and 31% in athletes, [...]
Aqua free Industries Expands Its Facilities and Capabilities for Advanced OEM Water Filter Solutions Worldwide
28/11/2024
Hamburg, [28. November 2024] – Aqua free Industries, a leader in innovative drinking water hygiene solutions, marks a new chapter with the inauguration of its state-of-the-art facility in Lommel, Belgium. This cutting- [...]
SenQuil® Launches Innovative Botanical Solutions to Redefine Industry Standards
28/11/2024
SenQuil® introduces innovative botanical formulations, combining nature and science to enhance skin health. The company prioritizes sustainability, transparency, and accessibility, offering products that address [...]
Rakovina Therapeutics Announces Private Placement Offering
28/11/2024
The Company has received initial commitments totaling over $800,000 from strategic investors in connection with the Offering VANCOUVER, British Columbia, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX [...]
Celularity Inc. Announces Receipt of Nasdaq Notification
27/11/2024
FLORHAM PARK, N.J., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a regenerative medicine company developing placental-derived allogeneic cell therapies and advanced [...]
Information on the total number of voting rights and shares
27/11/2024
REGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), November 27, 2024 , 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on [...]
Informations sur le nombre total de droits de vote et d'actions
27/11/2024
INFORMATION RÉGLEMENTÉE Informations sur le nombre total de droits de vote et d'actions Mont-Saint-Guibert (Belgique), le 27 novembre 2024, 22:30h CET / 16:30h ET – Conformément à l'article 15 de la loi du 2 mai 2007 [...]
OneMedNet Announces Receipt of Nasdaq Notice Regarding Delayed Form 10-Q
27/11/2024
MINNEAPOLIS, Nov. 27, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), a global provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World [...]
Applied Therapeutics Receives Complete Response Letter from U.S. FDA Regarding New Drug Application for Govorestat for Classic Galactosemia
27/11/2024
NEW YORK, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a biopharmaceutical company dedicated to creating transformative treatments for rare disease, today announced that the U.S. Food and [...]
Titan Pharmaceuticals, Inc. Announces Receipt of Notice from Nasdaq
27/11/2024
NEW YORK, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan”) today reported that it received a notice (the “5250 Notice”) on November 22, 2024 from the Listing Qualifications [...]
QIAGEN launches novel tools for customizing digital PCR assays and NGS panels for microbial analysis
27/11/2024
QIAGEN introduces market’s first customizable digital PCR assay design tool with advanced design algorithms tailored for diverse microbial applications and custom NGS panels // First-of-its-kind Custom Assay Design Tool [...]
Sensei Biotherapeutics to Participate in Citi’s 2024 Global Healthcare Conference
27/11/2024
BOSTON, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients [...]
Revolution Medicines to Host RAS(ON) Inhibitor Clinical Update Webcast on December 2, 2024
27/11/2024
REDWOOD CITY, Calif., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced [...]
Windtree Therapeutics Reports Third Quarter 2024 Financial Results and Provides Key Business Updates
27/11/2024
WARRINGTON, Pa., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for [...]

Pages